Profile image
By Market Study Report
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Cancer Gene Therapy Market – Industry Analysis, Size, Share, Growth, Trends and Forecast to 2024

Thursday, November 24, 2016 21:43
% of readers think this story is Fact. Add your two cents.

(Before It's News) adds “Cancer Gene Therapy Market Size By Type [Gene Induced Immunotherapy (Cytokine Gene Delivery, Tumor Antigen Gene Delivery), Oncolytic Virotherapy (Adenoviruses, Lentiviruses, Retrovirus, Adeno Associated Virus, Herpes Simplex Virus, Alphavirus, Vaccinia Virus, Simian Virus), Gene Transfer/Gene Replacement (Naked/Plasmid Vectors, Electroporation, Sonoporation, Magnetofection, Gene Gun)], Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, China, Japan, Mexico, Brazil, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 2024” new report to its research database. The report spread across 105 pages with table and figures in it.

Rapid technological breakthroughs and the rising acceptance of newly emerging genomic technologies like next-generation sequencing and high-density DNA microarrays is predicted to drive the canCancer Gene Therapy market growth. Furthermore, the government support for these technologies is predicted to further boost the industry trends over the coming years. For instance, centers for disease control and prevention (CDC) favors countrywide screening programs for breast cancer control and cervical & colorectal cancers among women falling in low-income groups or with no health insurance. As per Global Market Insights Inc. report, The canCancer Gene Therapy market worth USD 805.5 million in 2015, is anticipated to surpass USD 4.3 billion by 2024, growing at a CAGR of 20.7% over the period of 2016-2024.

Growing occurrence of cancer across the globe is expected to enrich the demand for gene therapy. As per the WHO report, cases of cancer are projected to increase by half and touch USD 15 million mark by the end of the decade. Cancer gene treatments are being carried out worldwide through various therapies such as oncolytic virotherapy, gene transfer, and gene induced immunotherapy.

U.S. CanCancer Gene Therapy Market size, by type, 2012 – 2024 (USD Million)

U.S. CanCancer Gene Therapy Market size, by type, 2012 – 2024 (USD Million)

The retroviral vector oncolytic virotherapy segment led the gene therapy industry in 2015 and is predicted to record a CAGR of 20.6% over the period of 2016-2024. It converts the single-stranded RNA into double-stranded DNA molecule that gradually integrates into the target genome and helps to stimulate the immune system.

The gene transfer therapy segment contributed about 46% of the overall revenue share in 2015 and is predicted to grow at a CAGR of 20.9% over the forecast timeframe. Furthermore, the gene induced immunotherapy segment contributed about 14% of the overall revenue share in 2015 and is projected to surpass USD 592.7 million by 2024. It is an innovative technique of adding new genes into cancer tumor that fights cancer cells.

Browse full table of contents and data tables @

The U.S. canCancer Gene Therapy market size worth USD 235 million in 2015, is predicted to grow at a CAGR of 20.9% over the forecast timeframe. Factors such as growing cases of cancers and acceptance of advanced methods of cancer treatments are predicted to drive the regional growth. In addition to this, heavy investments in R & D activities along with government support will boost the industry demand over the coming years.

The China market worth USD 99.6 million in 2015, is predicted to grow at a CAGR of 21% over the forecast period owing to increase in healthcare funding coupled with improvement in R & D facilities.

The Japan canCancer Gene Therapy market worth USD 78.2 million in 2015, is predicted to grow at a CAGR of 20.9% over the period of 2016-2024.

Request a sample copy @

The UK market worth USD 92 million in 2015, is anticipated to register a CAGR of 20.8% over the forecast timeline due to the rising occurrence of cancer along with increasing acceptance of gene technology.

Key industry participants include Amgen, SiBiono, GENELUX, Altor Bioscience Corporation, MolMed S.p.A, Shanghai Sunway Biotech Company limited, Gradalis, ZIOPHARM Oncology Incorporation, Aduro Biotech Incorporation, GlobeImmune Company, OncoGeneX, and New Link Genetics. These market participants will try to increase their revenue share by continuously investing in R & D activities to develop new methods of treatment. In addition to this, they will try to retain their market position by forming strategic alliances and through mergers & acquisitions.

Inquiry Before Buying @

To receive personalized assistance, write to us @ [email protected] with the report title in the subject line along with your questions or call us at +1 866-764-2150

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.